The Claim
Higher insulin receptor levels in breast tumors are positively correlated with larger tumor size, more advanced histological grading, and higher estrogen receptor content, suggesting potential relationships between insulin signaling and tumor progression markers.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
This claim says that when breast cancer tumors have more insulin receptors, they tend to be bigger, more aggressive, and have more estrogen receptors. It suggests that insulin might be playing a role in how breast cancer grows and develops.
See the scientific wording
Higher insulin receptor levels in breast tumors show positive correlations with larger tumor size, more advanced histological grading, and higher estrogen receptor content, suggesting potential relationships between insulin signaling and tumor progression markers.
What the research says
1 studyStudy: Elevated insulin receptor content in human breast cancer.
The study found that higher insulin receptor levels in breast tumors are linked to bigger tumors, more advanced cancer grades, and higher estrogen levels, just like the claim said.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.